Filter view on
Entry type
Status
Per-residue features
Colour by
Protein
GBC26160.1
Length
2,026 amino acids
Protein family membership
None predicted.
Domains and repeats
-
Domain741 - 842
- Retrotransposon gag domain (IPR005162)
961 - 989- Zinc finger, CCHC-type (IPR001878)
1,192 - 1,289- Aspartic peptidase domain (IPR021109)
- Peptidase A2A, retrovirus, catalytic (IPR001995)
1,418 - 1,597- Reverse transcriptase domain (IPR000477)
1,818 - 2,018
1
200
400
600
800
1000
1200
1400
1600
1800
2026
Detailed signature matches
no IPR
Unintegrated signatures
Residue annotation
-
Catalytic residue ...1,205D
-
catalytic motif cd...
-
inhibitor binding ...1,205Dinhibitor binding site
1,205D, 1,207G, 1,209A, 1,234I, 1,235I, 1,274I
CDD
cd00303 (retropepsin_like)1,207Ginhibitor binding site
1,205D, 1,207G, 1,209A, 1,234I, 1,235I, 1,274I
CDD
cd00303 (retropepsin_like)1,209Ainhibitor binding site
1,205D, 1,207G, 1,209A, 1,234I, 1,235I, 1,274I
CDD
cd00303 (retropepsin_like)1,234Iinhibitor binding site
1,205D, 1,207G, 1,209A, 1,234I, 1,235I, 1,274I
CDD
cd00303 (retropepsin_like)1,235Iinhibitor binding site
1,205D, 1,207G, 1,209A, 1,234I, 1,235I, 1,274I
CDD
cd00303 (retropepsin_like)1,274Iinhibitor binding site
1,205D, 1,207G, 1,209A, 1,234I, 1,235I, 1,274I
CDD
cd00303 (retropepsin_like) -
Active site flap c...1,234IActive site flap
1,234I, 1,235I, 1,236A, 1,240K, 1,241I, 1,242A, 1,243A
CDD
cd00303 (retropepsin_like)1,235IActive site flap
1,234I, 1,235I, 1,236A, 1,240K, 1,241I, 1,242A, 1,243A
CDD
cd00303 (retropepsin_like)1,236AActive site flap
1,234I, 1,235I, 1,236A, 1,240K, 1,241I, 1,242A, 1,243A
CDD
cd00303 (retropepsin_like)1,240KActive site flap
1,234I, 1,235I, 1,236A, 1,240K, 1,241I, 1,242A, 1,243A
CDD
cd00303 (retropepsin_like)1,241IActive site flap
1,234I, 1,235I, 1,236A, 1,240K, 1,241I, 1,242A, 1,243A
CDD
cd00303 (retropepsin_like)1,242AActive site flap
1,234I, 1,235I, 1,236A, 1,240K, 1,241I, 1,242A, 1,243A
CDD
cd00303 (retropepsin_like)1,243AActive site flap
1,234I, 1,235I, 1,236A, 1,240K, 1,241I, 1,242A, 1,243A
CDD
cd00303 (retropepsin_like) -
putative NTP bindi...1,484Dputative NTP binding site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,548D
CDD
cd01647 (RT_LTR)1,485Lputative NTP binding site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,548D
CDD
cd01647 (RT_LTR)1,486Aputative NTP binding site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,548D
CDD
cd01647 (RT_LTR)1,487Aputative NTP binding site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,548D
CDD
cd01647 (RT_LTR)1,488Gputative NTP binding site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,548D
CDD
cd01647 (RT_LTR)1,489Fputative NTP binding site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,548D
CDD
cd01647 (RT_LTR)1,518Fputative NTP binding site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,548D
CDD
cd01647 (RT_LTR)1,548Dputative NTP binding site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,548D
CDD
cd01647 (RT_LTR) -
putative active si...1,484Dputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,485Lputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,486Aputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,487Aputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,488Gputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,489Fputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,518Fputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,519Gputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,546Yputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,548Dputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,549Dputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,593Lputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR)1,594Gputative active site
1,484D, 1,485L, 1,486A, 1,487A, 1,488G, 1,489F, 1,518F, 1,519G, 1,546Y, 1,548D, 1,549D, 1,593L, 1,594G
CDD
cd01647 (RT_LTR) -
putative nucleic a...1,519G
-
active site cd092741,695D1,737E1,762D1,805D
-
RNA/DNA hybrid bin...1,695DRNA/DNA hybrid binding site
1,695D, 1,696A, 1,697S, 1,698G, 1,732P, 1,733I, 1,734T, 1,737E, 1,762D, 1,795H, 1,809R
CDD
cd09274 (RNase_HI_RT_Ty3)1,696ARNA/DNA hybrid binding site
1,695D, 1,696A, 1,697S, 1,698G, 1,732P, 1,733I, 1,734T, 1,737E, 1,762D, 1,795H, 1,809R
CDD
cd09274 (RNase_HI_RT_Ty3)1,697SRNA/DNA hybrid binding site
1,695D, 1,696A, 1,697S, 1,698G, 1,732P, 1,733I, 1,734T, 1,737E, 1,762D, 1,795H, 1,809R
CDD
cd09274 (RNase_HI_RT_Ty3)1,698GRNA/DNA hybrid binding site
1,695D, 1,696A, 1,697S, 1,698G, 1,732P, 1,733I, 1,734T, 1,737E, 1,762D, 1,795H, 1,809R
CDD
cd09274 (RNase_HI_RT_Ty3)1,732PRNA/DNA hybrid binding site
1,695D, 1,696A, 1,697S, 1,698G, 1,732P, 1,733I, 1,734T, 1,737E, 1,762D, 1,795H, 1,809R
CDD
cd09274 (RNase_HI_RT_Ty3)1,733IRNA/DNA hybrid binding site
1,695D, 1,696A, 1,697S, 1,698G, 1,732P, 1,733I, 1,734T, 1,737E, 1,762D, 1,795H, 1,809R
CDD
cd09274 (RNase_HI_RT_Ty3)1,734TRNA/DNA hybrid binding site
1,695D, 1,696A, 1,697S, 1,698G, 1,732P, 1,733I, 1,734T, 1,737E, 1,762D, 1,795H, 1,809R
CDD
cd09274 (RNase_HI_RT_Ty3)1,737ERNA/DNA hybrid binding site
1,695D, 1,696A, 1,697S, 1,698G, 1,732P, 1,733I, 1,734T, 1,737E, 1,762D, 1,795H, 1,809R
CDD
cd09274 (RNase_HI_RT_Ty3)1,762DRNA/DNA hybrid binding site
1,695D, 1,696A, 1,697S, 1,698G, 1,732P, 1,733I, 1,734T, 1,737E, 1,762D, 1,795H, 1,809R
CDD
cd09274 (RNase_HI_RT_Ty3)1,795HRNA/DNA hybrid binding site
1,695D, 1,696A, 1,697S, 1,698G, 1,732P, 1,733I, 1,734T, 1,737E, 1,762D, 1,795H, 1,809R
CDD
cd09274 (RNase_HI_RT_Ty3)1,809RRNA/DNA hybrid binding site
1,695D, 1,696A, 1,697S, 1,698G, 1,732P, 1,733I, 1,734T, 1,737E, 1,762D, 1,795H, 1,809R
CDD
cd09274 (RNase_HI_RT_Ty3)
GO term prediction
Biological Process
GO:0006508 proteolysis
Molecular Function
GO:0003676 nucleic acid binding
GO:0004190 aspartic-type endopeptidase activity
GO:0008270 zinc ion binding
Cellular Component
None predicted.